2.35
Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
36.17%
10.64
|
16.67 | 4.9816 | 2.8443 | 3.3741 |
| Operating Income/Loss |
36.17%
-10.64
|
-16.67 | -4.9816 | -2.8443 | -3.3741 |
|
|
113.93%
17.47
|
-125.40 | -283.67 | -2.744 | -3.2586 |
| Basic Average Shares |
6.15%
46.60
|
43.90 | - | 7.569 | 7.569 |
| Diluted Average Shares |
80.19%
79.10
|
43.90 | - | 7.569 | 7.569 |
| Basic Earnings Per Share |
112.59%
0.36
|
-2.86 | - | -0.36 | -0.43 |
| Diluted Earnings Per Share |
95.10%
-0.14
|
-2.86 | - | -0.36 | -0.43 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
0.8193
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):